IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 15, 2017
November 22, 2017 17:00 ET | India Globalization Capital
BETHESDA, Md., Nov. 22, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), adjourned again the voting for Proposals Three and Four from its Notice of Annual Meeting of...
India Globalization Capital Reports Second Quarter 2018 Financial Results and Operational Highlights
November 20, 2017 08:00 ET | India Globalization Capital
BETHESDA, Md., Nov. 20, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), today reported financial results for the second quarter ended September 30, 2017 and provided...
IGC Announces Results of Annual Shareholders Meeting
November 13, 2017 14:22 ET | India Globalization Capital
BETHESDA, Md., Nov. 13, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), announced that during its 2016-2017 Annual Meeting of Shareholders scheduled for, and convened...
India Globalization Capital Regains NYSE American Listing Compliance
November 10, 2017 08:00 ET | India Globalization Capital
BETHESDA, Md., Nov. 10, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) announced that it received a letter on November 9, 2017 from NYSE Regulation stating that it is...
IGC to Distribute its Formulations in Germany in Early 2018
October 25, 2017 08:00 ET | India Globalization Capital
BETHESDA, Md., Oct. 25, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE MKT:IGC) announced that it has entered into a Memorandum of Understanding (MOU) with MediCann Handels GmbH, a...
IGC-AD1 Targeting Alzheimer’s Disease to be commercialized in early 2018 Through Medical Dispensaries
October 18, 2017 08:00 ET | India Globalization Capital
BETHESDA, Md., Oct. 18, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides compelling in vitro data compiled from genetically engineered cell lines within an...
NYSE American Extends India Globalization Capital Compliance Plan Period
October 12, 2017 14:59 ET | India Globalization Capital
BETHESDA, Md., Oct. 12, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital Inc. (NYSE American:IGC) announces that on October 11, 2017 it received notice from NYSE American LLC (“the Exchange”)...
IGC Prepares a Liquid Delivery Formulation of IGC-AD1 for Alzheimer’s Based on Novel In Vitro Data
October 04, 2017 08:00 ET | India Globalization Capital
BETHESDA, Md., Oct. 04, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides an update on compelling in vitro data compiled from genetically engineered cell lines...
IGC Readies Line of Medical Dispensary Products Targeting Alzheimer’s Disease Based on Novel Data
September 18, 2017 08:00 ET | India Globalization Capital
BETHESDA, Md., Sept. 18, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides an update on compelling in vitro data compiled from genetically engineered cell lines...
IGC’s Drug Candidate for Alzheimer’s Potentially Presents New Molecular Pathway for THC to Inhibit Aβ40 Production
September 11, 2017 08:00 ET | India Globalization Capital
BETHESDA, Md., Sept. 11, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today provides an update on compelling in vitro data compiled from genetically engineered cell...